首页 | 本学科首页   官方微博 | 高级检索  
检索        

Lp-PLA2、PTX3对冠心病患者PCI术后支架内再狭窄的预测价值
引用本文:李令娟,刘冬,王卫娟,王宏伟,孙美娜.Lp-PLA2、PTX3对冠心病患者PCI术后支架内再狭窄的预测价值[J].心脏杂志,2023,35(2):162-167.
作者姓名:李令娟  刘冬  王卫娟  王宏伟  孙美娜
作者单位:1.心血管内科 廊坊市第四人民医院、承德医学院附属医院
基金项目:廊坊市科学技术研究与发展计划(2020013102)
摘    要:目的 探讨脂蛋白相关性磷脂酶A2(Lp-PLA2)、正五聚蛋白-3(PTX3)对冠状动脉粥样硬化性心脏病(CHD)患者经皮冠状动脉介入(PCI)术后支架内再狭窄(ISR)的预测价值。方法 选取因冠状动脉严重狭窄行PCI治疗的CHD患者379例。根据术后6个月复查是否发生ISR,分为ISR组(n=53)、非ISR组(n=326)。收集两组一般临床资料,监测两组术后1 d的Lp-PLA2和PTX3水平。采用Logistic逐步回归分析ISR发生的危险因素。术后6个月复查外弹力膜横截面积(EEM-CSA)、斑块面积(PLA)、最小管腔面积(MLA),内膜面积(IPA)及Gensini积分。分析Lp-PLA2和PTX3与Gensini积分、EEM-CSA、MLA、PLA、IPA的相关性。采用ROC曲线评估Lp-PLA2和PTX3预测ISR的最佳截断值与AUC。结果 (1)ISR组STEMI(P<0.05)、吸烟史(P<0.01)、糖尿病(P<0.01)、LDL-C(P<0.05)、支架串联(P<0.05)、应用分叉术式(P<0.01)、支架置入时长(P<...

关 键 词:冠状动脉粥样硬化性心脏病  经皮冠状动脉介入  支架内再狭窄  脂蛋白相关性磷脂酶A2  正五聚蛋白-3  冠脉造影  血管内超声  最佳截断值
收稿时间:2022-06-20

Predictive value of Lp-PLA2 and PTX3 for ISR after PCI in CHD patients
Institution:1.Department of Cardiovascular Medicine2.Department of Intervention, Fourth People’s Hospital of Langfang City & Affiliated Hospital of Chengde Medical College, Langfang 065700, Hebei, China
Abstract: AIM To investigate the predictive value of lipoprotein-associated phospholipase A2(Lp-PLA2) and pentraxin 3(PTX3) for in-stent restenosis (ISR) after percutaneous coronary intervention (PCI) in patients with coronary atherosclerotic heart disease (CHD). METHODS A total of 379 CHD patients undergoing PCI for severe coronary artery stenosis were selected. According to the reexamination of ISR 6 months after the operation, 53 cases were divided into ISR group and 326 cases were non-ISR group. General clinical data of patients in both groups were collected. Lp-PLA2 and PTX3 levels in both groups were monitored 1d after surgery. Logistic stepwise regression was used to analyze the risk factors of ISR.The cross-sectional area of the elastic membrane (EEM-CSA), plaque area (PLA), minimum lumen area (MLA), intima proliferation area (IPA) and Gensini score were reviewed 6 months after the operation. The correlation of Lp-PLA2 and PTX3 with Gensini score, EEM-CSA, MLA, PLA, IPA was analyzed. The optimum cut-off value and AUC of Lp-PLA2 and PTX3 for predicting ISR were evaluated by ROC curve. RESULTS (1) STEMI (P<0.05), smoking history (P<0.01), diabetes (P<0.01), LDL-C (P<0.05), stent tandem (P<0.05), bifurcation operation (P<0.01), stent placement duration (P<0.01), LP-PLA2 (P<0.05) and PTX3 (P<0.01) were higher in ISR group than in non-ISR group, HDL-C, LVEF and medication compliance were lower in ISR group than in non-ISR group (ALL P<0.05). Smoking (P<0.01), LDL-C (P<0.01), bifurcation procedure (P<0.01), diabetes (P<0.01), medication compliance (P<0.01), LP-PLA2 (P<0.05) and PTX3 (P<0.05) were independent risk factors for ISR. (2) The Gensini score of ISR group was higher than that of non-ISR group (P<0.01). Compared with the non-ISR group, the ISR group had larger IPA, PLA (all P<0.05) and smaller EM-CSA and MLA (all P<0.01). Lp-PLA2 and PTX3 were positively correlated with Gensini score, IPA and PLA (all P<0.01), but negatively correlated with EEM-CSA (all P<0.05) and MLA (all P<0.01). (3) The optimal truncation values of Lp-PLA2 and PTX3 for predicting ISR were 310.65 ng/ mL and 3.87 ng/ mL, respectively, and AUC were 0.780 (95%CI: 0.739-0.861) and 0.751 (95%CI: 0.751), respectively.The AUC of ISR predicted by LP-PLA2 combined with PTX3 was 0.832 (95%CI: 0.817-0.933), which was significantly higher than that predicted by LP-PLA2 and PTX3 alone (Z=3.083, P=0.021; Z=3.697, P=0.017). CONCLUSION ISR patients have higher lP-PLA2 and PTX3 levels after PCI, and monitoring of lP-PLA2 and PTX3 levels after PCI is helpful to predict the risk of ISR occurrence, the combined detection enhances the predictive value of ISR.
Keywords:
点击此处可从《心脏杂志》浏览原始摘要信息
点击此处可从《心脏杂志》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号